P. Ferlenga et al., CHARACTERIZATION OF BIG ENDOTHELIN-1-INDUCED CONTRACTION IN RABBIT SAPHENOUS ARTERY, Journal of cardiovascular pharmacology, 26, 1995, pp. 78-80
We have characterized the endothelin-converting enzyme (ECE)-like acti
vity involved in big endothelin (ET)-1-induced contraction in rabbit s
aphenous artery (RSA). Big ET-1 30 nM caused a contraction that was in
dependent of the vascular endothelium. Phosphoramidon and the neutral
endopeptidase (NEP) inhibitors thiorphan and candoxatrilat blocked the
vasoconstriction caused by big ET-1 in endothelium-denuded RSA. Cando
xatrilat (IC50 17 nM) and thiorphan (IC50 2.5 nM), were 5- to 30-fold
more potent than phosphoramidon (IC50 83 nM). Other protease inhibitor
s were inactive. In cultured endothelial cells the ET-1 release was in
hibited only by phosphoramidon (IC50 16 mu M) but at a concentration 2
00-fold that required an endothelium-denuded RSA. In conclusion, we ca
n speculate that the big ET-1 contraction in RSA is mediated by an ECE
, probably present on smooth muscle cells, which is susceptible to NEP
inhibitors and is different from the ECE on endothelial cells.